Khan, K. . Efficacy and Safety of Sitagliptin, Metformin and Pioglitazone Fixed-Dose Combination Therapy (100 mg/1000mg and 15 Mg Respectively) As a First-Line Treatment in Obese Type 2 Diabetes With High Insulin Resistance. IJMBS 2025, 9, 247-251.